Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AHCY | P23526 | 7/20 | 0.43 |
| ▸ | ADORA2B | P29275 | 1/20 | 0.41 |
| ▸ | OGA | O60502 | 1/20 | 0.35 |
| ▸ | SI | P14410 | 1/20 | 0.33 |
| ▸ | IRAK4 | Q9NWZ3 | 3/20 | 0.31 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29323457 | 1.00 | AHCY (0.43) | AHCYADORA2BOGASIIRAK4 | |
| SCHEMBL29323084 | 0.76 | AHCY (0.39) | AHCYADORA2BOGAADORA3 | |
| SCHEMBL29323466 | 0.76 | AHCY (0.39) | AHCYADORA2BOGAADORA3 | |
| SCHEMBL29323069 | 0.73 | AHCY (0.44) | AHCY | |
| SCHEMBL29323455 | 0.73 | AHCY (0.44) | AHCY | |
| SCHEMBL29323057 | 0.71 | LMNA (0.42) | ADORA2BIRAK4ADORA3 | |
| SCHEMBL29323444 | 0.71 | LMNA (0.42) | ADORA2BIRAK4ADORA3 | |
| SCHEMBL18016482 | 0.69 | AHCY (0.39) | AHCYADORA2BOGASIIRAK4 | |
| SCHEMBL10673149 | 0.61 | AHCY (1.00) | AHCYADORA2B | |
| SCHEMBL17547612 | 0.60 | LMNA (0.54) | AHCYADORA2B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240238323-A1 | MODIFIED NUCLEOSIDES AND NUCLEOTIDES ANALOGS AS ANTIVIRAL AGENTS FOR CORONA AND OTHER VIRUSES | EMORY UNIVERSITY | 2024-07-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240238323-A1 | MODIFIED NUCLEOSIDES AND NUCLEOTIDES ANALOGS AS ANTIVIRAL AGENTS FOR CORONA AND OTHER VIRUSES | MTAP, PNP, SARS1 | AHCY 804/4885ADORA2B 322/4885OGA 19/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.